Motivated by the loss of a patient, June-Wha Rhee, an instructor at the Stanford Cardiovascular Institute, leads a research effort to uncover the molecular mechanisms of hemochromatosis in the heart. Senior author Joseph Wu, the Simon H. Stertzer, MD, Professor, professor of radiology and of medicine, and director of Stanford’s Cardiovascular Institute, is also featured in this story.

In laboratory studies, Stanford Medicine researchers have found a way to regenerate the cartilage that eases movement between bones. Michael Longaker, the Deane P. and Louise Mitchell Professor in the School of Medicine and co-director of the Institute for Stem Cell Biology and Regenerative Medicine, and Charles Chan, clinical assistant professor of orthopaedic surgery, were interviewed during this segment.

Lawrence Steinman, the George A. Zimmermann Professor and professor of pediatrics, co-authored a list of likely biological factors underlying the reduced development of COVID-19 for children compared to adults.

California’s massive wildfires bring a host of health concerns for vulnerable populations, firefighters and others. Kari Nadeau and Mary Prunicki of Stanford’s Sean N. Parker Center for Allergy and Asthma Research discuss related threats, preparedness and ongoing research.

In laboratory studies, Stanford Medicine researchers, led by Michael Longaker, the Deane P. and Louise Mitchell Professor in the School of Medicine and co-director of the Institute for Stem Cell Biology and Regenerative Medicine, and Charles K.F. Chan, assistant professor of surgery, have found a way to regenerate the cartilage that eases movement between bones.

Protein levels in people’s blood can predict their age, a Stanford study has found. The study also found that aging isn’t a smoothly continuous process.

CAR-T cells are remarkably effective against blood cancers, but their effect can be transient as the cells become exhausted. Stanford researchers found a way to keep the cells effective in mice with human tumors.

Hongjie Dai, Julie Parsonnet and Joseph Wu are among the 90 regular members and 10 international members elected this year to the academy, which aims to provide independent, scientifically informed analysis and recommendations on health issues.

“Never could I have imagined the work I am doing now – not even ten years ago.” - Devavani Chatterjea, PhD, MPH

Researchers at Stanford and UCSF slowed the spread of a type of nonsmall cell lung cancer in mice by neutralizing a single protein that would otherwise set off a chain reaction, causing runaway tumor growth.

Andra Blomkalns, Gerald Grant, David Kingsley and Crystal Mackall have been appointed to endowed professorships.

Prasanna Jagannathan said the $100,000 prize will allow his lab team to ramp up their research in Uganda.

Michal Caspi Tal, PhD Postdoctoral Research Fellow, Stem Cell Biology and Regenerative Medicine, Stanford University, leads the infectious disease team within Irving Weissman’s lab at Stanford University receives the 2018 Emerging Leader Award ($100,000 grant).

David Schneider, whose research focuses on resilience to infection and developing mathematical models to predict recovery and well-being, succeeds Peter Sarnow in post.

In the trial, a new drug proved safe and effective for hard-to-treat rheumatoid arthritis patients. A national organization of senior researchers named the trial one of the top 10 for 2016.

A common signaling pathway unites diverse fibrotic diseases in humans, Stanford researchers have found. An antibody called anti-CD47, which is being tested as an anti-cancer agent, reverses fibrosis in mice.

To develop a potential antiviral treatment, Stanford researchers adopted an unusual approach: Rather than trying to disable viral enzymes, they targeted proteins the infected individual makes — and the virus needs.

The researchers will be given funding by the Chan Zuckerberg Biohub to develop tools and technologies that support the organization’s goal of curing, preventing or managing every disease.

Stanford researchers and their collaborators have found a way to tell whether patients with systemic sclerosis were improving during drug treatment a year before a standard clinical test could.

The California Institute for Regenerative Medicine awarded Samuel Strober, MD, $6.6 million to study a “deceptively simple” way to help kidney transplant recipients tolerate their new organ.

The medical school professors were awarded the grants as part of a large-scale National Institutes of Health program to study the biology of how physical activity improves health.

Stanford faculty members in medicine and in Earth science have been elected fellows of the American Association for the Advancement of Science.

The FDA is funding a collaboration between Stanford and UCSF to improve the regulatory infrastructure that helps to shape modern biomedical research.